Latest filing published 31 Aug 2023 for C4 Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Lauren White: trading record in brief
Lauren White, listed as finance chief, appears in our data through filings on C4 Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 7 filings, for trades running from 25 May 2022 to 30 August 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 31 August 2023, the filings show a share grant worth €1,772 in C4 Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Lauren White
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,250 sharesCommon StockSEC:0001662579-23-000084:0
- 26,000 shares0Common StockSEC:0001662579-23-000035:0
- 3,750 sharesCommon StockSEC:0001662579-23-000023:0
- 1,102 shares@ US$7.01100.0% of flowCommon StockSEC:0001209191-22-036714:0
- 3,750 sharesCommon StockSEC:0001209191-22-032509:0
5 of 5 declarations
